Suppr超能文献

苏丹内脏利什曼病患者血液中IgM、IgA、IgG及IgG亚类水平的意义

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients.

作者信息

Elassad A M, Younis S A, Siddig M, Grayson J, Petersen E, Ghalib H W

机构信息

Department of Microbiology, College of Medicine, University of Juba.

出版信息

Clin Exp Immunol. 1994 Feb;95(2):294-9. doi: 10.1111/j.1365-2249.1994.tb06526.x.

Abstract

We developed an ELISA test using leishmania antigenic extracts to detect antigen-specific antibody responses, including subclass and isotype analysis, in visceral leishmaniasis (VL) patients from the Sudan. A total of 92 parasitologically proven patients were compared with cutaneous leishmaniasis, schistosomiasis, malaria, onchocerciasis and tuberculosis patients, as well as with healthy endemic and non-endemic controls. Some VL patients were examined before and after chemotherapy. VL patients showed significantly higher IgG responses compared with all other groups (93.4% sensitivity, 93.7% specificity), and higher (but not significantly) IgM responses. All groups showed low IgA levels. All IgG subclasses, IgG1, 2, 3, and 4, showed higher levels in patients than all other groups, with IgG1 and IgG3 levels being significantly reduced following treatment. The rank order for specificity and sensitivity for IgG subclasses was IgG3 > IgG1 > IgG2 > IgG4.

摘要

我们开发了一种酶联免疫吸附测定(ELISA)试验,使用利什曼原虫抗原提取物来检测苏丹内脏利什曼病(VL)患者的抗原特异性抗体反应,包括亚类和亚型分析。总共92例经寄生虫学证实的患者与皮肤利什曼病、血吸虫病、疟疾、盘尾丝虫病和结核病患者,以及健康的流行区和非流行区对照进行了比较。一些VL患者在化疗前后接受了检查。与所有其他组相比,VL患者表现出显著更高的IgG反应(敏感性93.4%,特异性93.7%),以及更高(但不显著)的IgM反应。所有组的IgA水平都很低。所有IgG亚类,即IgG1、2、3和4,在患者中的水平均高于所有其他组,治疗后IgG1和IgG3水平显著降低。IgG亚类的特异性和敏感性排序为IgG3 > IgG1 > IgG2 > IgG4。

相似文献

1
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients.
Clin Exp Immunol. 1994 Feb;95(2):294-9. doi: 10.1111/j.1365-2249.1994.tb06526.x.
3
Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2675. doi: 10.1371/journal.pntd.0002675. eCollection 2014 Feb.
5
Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.
Clin Exp Immunol. 1998 Dec;114(3):408-13. doi: 10.1046/j.1365-2249.1998.00752.x.
7
Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
Trans R Soc Trop Med Hyg. 2012 Nov;106(11):668-76. doi: 10.1016/j.trstmh.2012.07.005. Epub 2012 Aug 21.
8
Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.
Trop Med Int Health. 2001 Feb;6(2):108-13. doi: 10.1046/j.1365-3156.2001.00680.x.
10
IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.
PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3273. doi: 10.1371/journal.pntd.0003273. eCollection 2014 Oct.

引用本文的文献

1
Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis.
Front Immunol. 2025 Mar 31;16:1540537. doi: 10.3389/fimmu.2025.1540537. eCollection 2025.
2
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
Microorganisms. 2021 Dec 2;9(12):2500. doi: 10.3390/microorganisms9122500.
3
Infection of dogs by Leishmania infantum elicits a general response of IgG subclasses.
Sci Rep. 2020 Nov 2;10(1):18826. doi: 10.1038/s41598-020-75569-6.
5
Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.
Pathog Glob Health. 2014 Dec;108(8):381-4. doi: 10.1179/2047773214Y.0000000166. Epub 2014 Dec 9.
6
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.
Antimicrob Agents Chemother. 2015 Jan;59(1):1-14. doi: 10.1128/AAC.04298-14. Epub 2014 Nov 3.
7
IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.
PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3273. doi: 10.1371/journal.pntd.0003273. eCollection 2014 Oct.
8
Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.
Eur J Immunol. 2010 May;40(5):1355-68. doi: 10.1002/eji.200939455.
9
Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.
J Immunol. 2007 Jan 15;178(2):1077-85. doi: 10.4049/jimmunol.178.2.1077.
10
Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis.
Clin Vaccine Immunol. 2006 Oct;13(10):1104-10. doi: 10.1128/CVI.00188-06.

本文引用的文献

3
Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north.
Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):395-8. doi: 10.1016/0035-9203(93)90010-n.
6
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.
N Engl J Med. 1980 Jul 24;303(4):178-82. doi: 10.1056/NEJM198007243030402.
9
Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis.
J Immunol Methods. 1983 Jan 28;56(2):201-7. doi: 10.1016/0022-1759(83)90412-x.
10
An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis.
Am J Trop Med Hyg. 1983 Sep;32(5):943-6. doi: 10.4269/ajtmh.1983.32.943.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验